微量アスピリン・チクロピヂン併用・患者別コントロールによる抗血小板療法の研究 : 第二報 脳梗塞再発防止についての中間報告
晃 服部, Ichiro Fuse, 亘 帯刀 et al. · Institutional Repositories DataBase (IRDB) · 1990
We have studied antiplatelet therapy by low-dose aspirin combined with ticlopidine under the control of platelet aggregation individually for secondary prevention of cerebral infarction (CI) and a preliminary results were reported. Eighty six patients (9 with TIA, 2 with RIND or 75 with CI) were treated by our protocol (Niigata Med. J. 101;642, 1987) for an average of 22 months. The doses of drugs were for aspirin at 10-75 (median 30) mg/day and for ticlopidine at 50-300 (median 200) mg/day. Cerebrovascular reattacks in all and recurrence of CI were 3.18% and 2.08% (patient x year), respectively. Mild non-fatal bleeding occurred in 4 patients. None of patients died during this study. In conclusion our method is turned out, at least, as effective as those reported by others, and seems safe in clinical application.
Cited by 0 works.